Added to YB: 2026-02-09
Pitch date: 2026-02-06
ERF.PA [neutral]
Eurofins Scientific SE
-1.35%
current return
Author Info
D Invests is a self taught investor with a focus on quality and value. This newsletter focuses on businesses within their portfolio past and present. Their aim is to double their investments every 5 years resulting in a target 15% CAGR. Sign up for the newsletter.
Company Info
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
Market Cap
EUR 12.0B
Pitch Price
EUR 68.34
Price Target
140.00 (+108%)
Dividend
1.06%
EV/EBITDA
10.41
P/E
30.42
EV/Sales
2.15
Sector
Life Sciences Tools and Services
Category
growth
Eurofins Scientific FY2025 Review
ERF.PA (earnings): Q4 results showed 5% revenue growth to €7.3B, 22.5% EBITDA margin (+20bps), 12.8% ROCE (+180bps). 40 acquisitions for €261M, 14 new start-ups. Heavy buybacks at €46 low, reducing shares 5.5%. Nearing end of investment cycle, FCF expected to boost post-2027. Target: €124-140 by 2030 (12.7-15.5% IRR).
Read full article (8 min)